正大企业国际(03839.HK)：董事长谢吉人由非执行董事调任为执行董事

Group 1 - The company announced changes effective from February 24, 2026, including the appointment of its chairman, Xie Jiren, as an executive director due to his new executive role within the group [1] - Li Shaozhu resigned as executive director and CEO (Industrial Business) to focus on personal matters, and he will no longer be a member of the board's remuneration committee [1] - Kobboon Srichai has been appointed as a non-executive director of the company [1] Group 2 - Current executive director Ma Deshou has been appointed as the CEO and a member of the remuneration committee [1] - Following Ma Deshou's appointment, Li Shaoqing will no longer serve as CEO (Biochemical Business) but will remain as an executive director [1]